Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation

NCT01967888 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatectomy for Chronic Pancreatitis

Interventions

DRUG: Reparixin
DRUG: Placebo

Sponsor

Dompé Farmaceutici S.p.A